Spectral AI, Inc. ($MDAI), poised to redefine the future of healthcare. With a current stock price of $2.8677 and a market cap of $44.15M, Spectral AI's foray into the AI-driven healthcare sector is capturing investor attention. Despite the volatility highlighted by the 52-week high/low of $19.5/$1.9, the focus remains on the company's strides in innovation. The enrollment of the first patient in the pivotal study for DeepView AI marks a significant milestone, setting the stage for potential FDA marketing authorization in 2025. Spectral AI's outstanding shares at 16.29M reflect investor confidence in the company's vision.